Diehl V - Search Results

1

Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.

Fisher RI, Bostick-Bruton F, Sauder DN, Scala G, Diehl V. Fisher RI, et al. Among authors: diehl v. J Immunol. 1983 Jun;130(6):2666-70. J Immunol. 1983. PMID: 6222113

2

Antigen presentation by Hodgkin's disease cells.

Fisher RI, Cossman J, Diehl V, Volkman DJ. Fisher RI, et al. Among authors: diehl v. J Immunol. 1985 Nov;135(5):3568-71. J Immunol. 1985. PMID: 3876389

3

Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.

Fisher RI, Bates SE, Bostick-Bruton F, Tuteja N, Diehl V. Fisher RI, et al. Among authors: diehl v. J Immunol. 1984 May;132(5):2672-7. J Immunol. 1984. PMID: 6609204

4

Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease.

Kniep B, Monner DA, Burrichter H, Diehl V, Mühlradt PF. Kniep B, et al. Among authors: diehl v. J Immunol. 1983 Sep;131(3):1591-4. J Immunol. 1983. PMID: 6886427

5

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.

Loeffler M, Brosteanu O, Hasenclever D, Sextro M, Assouline D, Bartolucci AA, Cassileth PA, Crowther D, Diehl V, Fisher RI, Hoppe RT, Jacobs P, Pater JL, Pavlovsky S, Thompson E, Wiernik P. Loeffler M, et al. Among authors: diehl v. J Clin Oncol. 1998 Mar;16(3):818-29. doi: 10.1200/JCO.1998.16.3.818. J Clin Oncol. 1998. PMID: 9508162

6

Hodgkin's disease cell lines: characteristics and biological activities.

Diehl V, Burrichter H, Schaadt M, Kirchner HH, Fonatsch C, Stein H, Gerdes J, Heit W, Ziegler A. Diehl V, et al. Haematol Blood Transfus. 1983;28:411-7. doi: 10.1007/978-3-642-68761-7_81. Haematol Blood Transfus. 1983. PMID: 6305805

7

Interleukin-1-like activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte co-stimulator assay.

Kortmann C, Burrichter H, Monner D, Jahn G, Diehl V, Peter HH. Kortmann C, et al. Among authors: diehl v. Immunobiology. 1984 May;166(3):318-33. doi: 10.1016/s0171-2985(84)80049-2. Immunobiology. 1984. PMID: 6610630

8

Revised response criteria for malignant lymphoma.

Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Cheson BD, et al. Among authors: diehl v. J Clin Oncol. 2007 Feb 10;25(5):579-86. doi: 10.1200/JCO.2006.09.2403. Epub 2007 Jan 22. J Clin Oncol. 2007. PMID: 17242396

9

Evidence for the detection of the normal counterpart of Hodgkin and Sternberg-Reed cells.

Stein H, Gerdes J, Schwab U, Lemke H, Diehl V, Mason DY, Bartels H, Ziegler A. Stein H, et al. Among authors: diehl v. Hematol Oncol. 1983 Jan-Mar;1(1):21-9. doi: 10.1002/hon.2900010105. Hematol Oncol. 1983. PMID: 6677560

10

Two neoplastic cell lines with unique features derived from Hodgkin's disease.

Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner HH. Schaadt M, et al. Among authors: diehl v. Int J Cancer. 1980 Dec 15;26(6):723-31. doi: 10.1002/ijc.2910260605. Int J Cancer. 1980. PMID: 7216541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters